| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 145.715 | 148.807 | 178.692 | 178.634 | 206.886 | 309.705 | 537.514 | 477.878 | 396.004 | 405.216 |
| Total Income - EUR | 179.071 | 149.962 | 179.090 | 178.918 | 207.857 | 316.310 | 564.247 | 485.575 | 434.124 | 425.836 |
| Total Expenses - EUR | 177.405 | 138.592 | 165.579 | 173.810 | 193.960 | 209.337 | 269.344 | 314.253 | 349.776 | 358.902 |
| Gross Profit/Loss - EUR | 1.666 | 11.371 | 13.511 | 5.108 | 13.897 | 106.973 | 294.903 | 171.322 | 84.348 | 66.934 |
| Net Profit/Loss - EUR | 770 | 9.034 | 11.725 | 3.324 | 11.830 | 103.923 | 289.528 | 166.543 | 80.385 | 57.319 |
| Employees | 11 | 11 | 10 | 10 | 12 | 12 | 11 | 11 | 10 | 9 |
Check the financial reports for the company - Oxiline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124.153 | 121.678 | 110.339 | 101.440 | 116.378 | 114.975 | 123.192 | 134.282 | 161.659 | 138.687 |
| Current Assets | 64.056 | 51.152 | 45.556 | 39.160 | 42.622 | 135.917 | 340.072 | 280.726 | 324.969 | 165.709 |
| Inventories | 2.153 | 1.768 | 2.170 | 4.719 | 4.793 | 6.349 | 10.321 | 8.406 | 3.171 | 4.504 |
| Receivables | 22.758 | 18.949 | 21.317 | 23.645 | 23.866 | 69.982 | 111.374 | 29.100 | 67.510 | 32.842 |
| Cash | 39.145 | 30.436 | 22.068 | 10.796 | 13.963 | 59.585 | 218.377 | 243.220 | 254.288 | 128.364 |
| Shareholders Funds | 175.480 | 159.097 | 141.331 | 126.916 | 129.855 | 202.283 | 403.699 | 233.234 | 353.344 | 123.436 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.247 | 15.573 | 16.143 | 14.242 | 29.205 | 48.760 | 59.565 | 181.774 | 133.284 | 180.961 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2011 - 2011" | |||||||||
| CAEN Financial Year |
2011
|
|||||||||
Comments - Oxiline Srl